Approval · Notice of Compliance 1138 · 2000
RECORMON: Notice of Compliance 1138
Issued September 20, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1138
- Date
- September 20, 2000
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Erythropoiesis regulating hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RECORMON | 02242894 | — |
| RECORMON | 02242895 | — |
| RECORMON | 02242896 | — |
| RECORMON | 02242897 | — |
| RECORMON | 02242898 | — |
| RECORMON | Not yet assigned | — |
| RECORMON | 02242899 | — |
| RECORMON | 02242900 | — |
Medicinal ingredients
- EPOETIN BETA 500 UNIT per VIAL
- EPOETIN BETA 1,000 UNIT per VIAL
- EPOETIN BETA 2,000 UNIT per VIAL
- EPOETIN BETA 5,000 UNIT per VIAL
- EPOETIN BETA 10,000 UNIT per VIAL
- EPOETIN BETA 20,000 UNIT per VIAL
- EPOETIN BETA 50,000 UNIT per VIAL
- EPOETIN BETA 100,000 UNIT per VIAL